UBS Group »

Seaport Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Seaport Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Seaport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seaport Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seaport Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.1M 279k 21.72

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Seaport Therapeutics

Arch Venture Corp
General Atlantic
Sofinnova Ventures
Goldman Sachs Group
Trv Gp Vi
Canada Pension Plan Investment Board
Jpmorgan Chase & Co
Foresite Capital Management VI
FMR
Bellevue Group
Siren
Jennison Associates
RA Capital Management
Vanguard Capital Management
Woodline Partners

View all funds holding Seaport Therapeutics